Product Description
Lapatinib 250mg Tablets are designed for the treatment of HER2-positive breast cancer. Each tablet contains 250mg of Lapatinib, an anti-cancer medication. Recommended for patients with advanced or metastatic HER2-positive breast cancer, the dosage guidelines typically involve taking one tablet daily or as prescribed by an oncologist. The Lapatinib Ditosylate Monohydrate composition ensures effectiveness in combating the disease. With 30 tablets per bottle, this product is suitable for adults and should be stored at room temperature away from moisture and light.
FAQs of Lapatinib 250mg Tablets:
Q: What is the recommended dosage for Lapatinib 250mg Tablets?
A: The recommended dosage is 250mg per tablet, typically taken once daily or as prescribed by an oncologist.
Q: What is the main function of Lapatinib 250mg Tablets?
A: The main function is the treatment of HER2-positive breast cancer in patients with advanced or metastatic conditions.
Q: How should Lapatinib 250mg Tablets be stored?
A: These tablets should be stored at room temperature (20-25C) and kept away from moisture and light.
Q: How many tablets are included in each bottle of Lapatinib 250mg Tablets?
A: Each bottle contains 30 tablets of Lapatinib 250mg.
Q: What is the origin of Lapatinib 250mg Tablets?
A: Lapatinib 250mg Tablets are allopathic in nature.